Overview
Pharmacokinetics of Faldaprevir of Soft Capsule
Status:
Completed
Completed
Trial end date:
2013-05-01
2013-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of the trial is to assess the bioavailability of Faldaprevir soft capsule with single oral dose and multiple oral doses in Chinese subjectsPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Boehringer Ingelheim
Criteria
Inclusion criteria:Healthy male and female subjects
Exclusion criteria:
Any relevant deviation from healthy conditionsAny relevant deviation from healthy
conditions